Neuropsychiatric EEG-Based Assessment Aid (NEBA)
Jump to navigation
Jump to search
Indications
- assessment of attention-deficit/hyperactivity disorder (ADHD) in children & adolescents 6-17 years of age[1]
Clinical significance
- theta wave/beta wave ratio is higher in children & adolescents with ADHD than in children without
Procedure
- 15-20-minute non-invasive test that calculates the ratio of EEG theta wave & EEG beta wave frequencies
Notes
- device/procedure not without skeptics
More general terms
References
- ↑ 1.0 1.1 FDA News Release: July 15, 2013 FDA permits marketing of first brain wave test to help assess children and teens for ADHD. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm360811.htm